I would be interested to receive information from other users on how the assay is performing at present
I currently have significant concerns that the assay is not performing to specification and may not be suitable for designation as a contemporary troponin assay
according to the Apple criteria. This is a worry as previously it was a borderline “sensitive” assay.
It would also appear that the current performance means it may not be suitable for rapid ED rule out of chest pain
Please reply directly to me
Best wishes
Professor Paul Collinson |
T: +44 (0)208 725 5934 sec (0)208 725 5923 |
Consultant Chemical Pathologist and Professor of Cardiovascular Biomarkers
|
F: +44 (0)208 725 5868 |
Clinical Blood Sciences |
|
|
P
Save Paper - Do you really need to print this e-mail?